Prostate cancer stands as the most prevalent malignancy affecting men worldwide, impacting approximately 4 million individuals in the United States...

A comprehensive new review that assessed billions of doses of currently approved mRNA vaccines affirms that these vaccines provide protection...

A groundbreaking study from Southern Medical University in Guangzhou, China, unveils a remarkable interaction between a common probiotic bacterium and...

Antibody-drug conjugates (ADCs) have emerged as revolutionary agents in oncology, representing a precision-guided approach that targets cancer cells with high...

Ovarian cancer presents one of the most daunting challenges in oncology, marked by its notorious capacity to initially respond to...

A groundbreaking case report recently published in the May 2026 issue of Oncoscience sheds new light on the complexities of...

In the relentless battle against lung cancer, early detection remains a cornerstone strategy to improve survival rates. A recent prospective...

In a groundbreaking advance for oncology and personalized cancer therapy, the European GAMBIT study unravels critical insights into the risk...

In a landmark advancement for the treatment of advanced breast cancer, the U.S. Food and Drug Administration (FDA) has granted...

In the ever-evolving landscape of oncology, the TP53 gene remains a focal point due to its pivotal role in the...